Ganglioside and related-sphingolipid profiles are altered in a cellular model of Alzheimer's disease
Abstract
No abstract availableKeywords
Funding Information
- University of Poitiers
- French Ministry of Education and Research and Technology
This publication has 45 references indexed in Scilit:
- Generation of Alzheimer Disease-associated Amyloid β42/43 Peptide by γ-Secretase Can Be Inhibited Directly by Modulation of Membrane ThicknessJournal of Biological Chemistry, 2012
- Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Comparison of Pharmacological Modulation of APP Metabolism in Primary Chicken Telencephalic Neurons and in a Human Neuroglioma Cell LineJournal of Molecular Neuroscience, 2010
- Ganglioside Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease: Expression of Chol-1α Antigens in the BrainASN Neuro, 2010
- Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's diseaseNeurobiology of Aging, 2010
- Deregulation of sphingolipid metabolism in Alzheimer's diseaseNeurobiology of Aging, 2010
- ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brainNeurobiology of Aging, 2009
- JNK regulates APP cleavage and degradation in a model of Alzheimer's diseaseNeurobiology of Disease, 2009
- Thematic Review Series: Sphingolipids. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease—a reviewJournal of Lipid Research, 2008